If I heard right and correct me if I'm wrong but I think Leo said the only reason it's called a 1b/2 ovarian trial is because of the very toxic properties of the drug they are combining kevetrin with for this trial. I also heard him say it's a phase 2 trial. I guess it essentially is but they need the 1b because of the toxic nature of the chemo drug they are pairing with.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links